This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In part 2 of our Q&A, Okamura addresses the need for biopharma companies to leverage digital technologies in disease management. The post Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for Prescription Medicine Business appeared first on MedCity News.
As people move up the pharma ladder, their work often revolves around internal management issues, training, and endless meetings to motivate their employees rather than focus on patients. Pharma likes to believe its own propaganda that everything they do is patient-focused, but that’s a canard.
Introduction In the highly regulated world of pharmaceutical marketing , mastering Google Ads management can be a game-changer. With millions of healthcare professionals (HCPs) and patients turning to Google for medical information, paid search ads present a huge opportunity for pharma brands to boost engagement and conversions.
Pharma DTC marketing is unique, and drug marketers need to think more about the journey from awareness to requesting an Rx. The hottest pharma product is Lilly’s diabetes drug, hyped by the media as helping patients lose weight. The post Uniqueness if pharma DTC. appeared first on World of DTC Marketing.com.
Medication adherence is a large and growing challenge for pharma companies, healthcare providers and the patients they serve. Research shows that 20% of patients have failed to fill a script in the past, and one-third aren’t confident managing their illness. In the U.S. Engaging patients from the moment a drug is prescribed can help.
SUMMARY: The biggest argument against pharma is the cost of prescription drugs. Pharma could do something about this by simply uniting to make it easier for patients who can’t afford their medications to get them free or at little cost.
SUMMARY: The biggest threat to the pharma industry isn’t the coming tsunami of healthcare changes. The content was sponsored by the brand but was written by leading cancer physicians with titles like “how to manage your cancer therapies” and “what to tell your Oncologist.” Brand awareness skyrocketed.
As privacy regulations evolve, customer expectations change, and AI-driven technologies emerge, pharma marketers must adapt or risk becoming irrelevant. In this article, we explore how data-driven marketing empowers pharma brands to be more precise, predictive, and effective in their outreach efforts.
Can pharma leverage influencer marketing? People are turning to their favorite Instagram stars, Twitter personalities, and YouTubers for advice and recommendations on purchasing decisions, but does this apply to prescription drugs? Influencers have already been talking about pharma. The post Influencer marketing in pharma.
Using the same ads to advertise prescription drugs repeatedly is a waste of money and doesn’t lead to sales. Nowhere is this clearer than in pharma DTC TV ads. A Prevention Magazine study dated had prescription DTC ads as being 7% effective in driving new Rx’s. DTC managers are often surprised by the results.
Introduction In todays fast-paced world, pharma digital marketing is more than just a strategyit’s a necessity. But how can pharma marketers break through the noise, engage their audience, and see real ROI? Drive prescription intent by educating HCPs about the latest drug advancements.
Artificial intelligence (AI) is no longer a futuristic concept in healthcareits here, embedded in nearly every touchpoint of modern pharma marketing. But as pharma marketers race to adopt these tools, a central question looms: Is AI fueling smarter engagement, or setting the stage for a compliance disaster? Key pillars include: 1.
PhRMA has rounded up its attack ad team once again for another broadside against pharmacy benefit managers, zeroing in this time on the potential for insurers to profit from where prescriptions get | PhRMA has rounded up its attack ad team once again for another broadside against pharmacy benefit managers, zeroing in this time on the potential for (..)
Retail price increases for widely used brand name prescription drugs consistently exceeded the rate of general inflation between 2006 and 2020. In 2020, retail prices for 260 brand-name prescription drugs widely used by older adults increased by an average of 2.9 The post The perfect storm is coming for pharma.
Digital pharma marketers have to “sell” the organization on the promise of digital marketing, but they also need to communicate that along with successes, there could be many failures. To master digital marketing, pharma needs to be prepared to fail. I’m optimistic that pharma can make it happen.
The “sales cycle” for prescription drugs has gotten more difficult to measure because of the pandemic. ” Today analytic people have to ensure that managers understand certain metrics’ importance while ignoring others like total visitors versus bounce rate. ” So how should DTC marketers really measure ROI?
In the world of pharma marketing, the strategies that truly resonate are often those rooted in trust. But how does referral marketing work in a highly regulated industry like pharma? This article explores the evolving role of referral marketing in pharma, unpacking its mechanics, benefits, compliance considerations, and future outlook.
SUMMARY: Today, more physicians and patients rely on the Internet to answer their questions about emerging treatments, including prescription drugs. If there is one industry that needs to think more about digital, it’s pharma. This is a severe concern in an era where more HCPs are refusing to meet with pharma reps.
Talented marketers don’t want a career in pharma because of the culture. Many pharma agencies have allowed and sometimes forced experienced, talented people to leave while replacing them with inexpensive unproven people, and it shows. 1ne: Pharma companies are forcing out older, experienced employees. Pure fantasy.
4our: Again, across all groups , they wanted information on “living with…” However, they wanted this information to be updated and included suggestions on exercise, diet, and supplements to manage chronic health issues. 9ine: “Why aren’t pharma websites updated?” 10en: eMail communications.
In a world dominated by digital conversations, failing to master pharma digital marketing is no longer an optionits a risk to market performance. Pharma marketers today must navigate not only consumer expectations but also a tightly regulated environment. Pharma brands were forced to adapt rapidly.
Introduction Pharma marketing is constantly evolving, with new digital tools, regulatory updates, and data-driven strategies shaping the industry. How do pharma marketing executives ensure they are using the best tools and strategies? However, with so much information available, finding the right resources can feel overwhelming.
Zoom Rx recently polled HCPs and found 78% of physicians want to maintain some contact with pharma reps. The most desired information doctors now want is about patient assistance programs, with 49% saying they want pharma reps to provide that information. Where to start? First, this data is not my specialty and is generalized.
When CVS Caremark removed AbbVie’s Humira from its national commercial formularies back in April, biosimilar prescriptions picked up at a whirlwind pace. Following CVS Caremark's lead, Cigna's pharmacy benefit manager unit will nix Humira from formularies in favor of Humira biosimilars from Boehringer Ingelheim, Teva and Sandoz.
Artificial intelligence is revolutionizing how pharma brands engage with healthcare professionals (HCPs) and patients, optimizing advertising campaigns, and improving customer experiences. As competition in the healthcare space intensifies, pharma brands that fail to integrate AI risk falling behind.
In today’s competitive healthcare landscape, PPC campaigns (Pay-Per-Click advertising) have emerged as a critical lever for pharma marketers aiming to deliver timely, targeted, and measurable impact. This intent-driven nature gives pharma companies a distinct advantagereaching consumers when theyre most receptive.
Specialty therapy patients require accessible prescriptionmanagement solutions that can simplify communication, improve access, and increase adherence. Today, gaining consistent access to life-saving medications can be a significant hurdle that many patients must learn to navigate.
Among the 26% of respondents who talked to a health care provider about a specific prescription drug they saw advertised, 16% said they received a prescription for the advertised drug. Online research is used to evaluate new prescription drugs. But is this really true across all DTC? What are the side effects?
Social media advertising now plays a crucial role in reaching healthcare professionals (HCPs) and patients , allowing pharma brands to engage, educate, and build trust like never before. But heres the challenge: strict industry regulations make social media advertising tricky for pharma marketers.
Over one-third struggle with basic health tasks, such as following prescription-drug directions. In other words, nearly nine out of 10 adults lack the skills needed to fully manage their health care and prevent disease. This is a huge opportunity for pharma to help patients. Nearly 36 percent of adults in the U.S.
Pharma companies, for the most part, still rely on outside digital agencies for their online work. Here are some of the things I learned in working with digital agencies at pharma. Prescription drug marketing is a lot different than selling CPG. Like anything, some agencies are better than others. 1ne: How big are they?
The Role of AI in CRM: Transforming Pharma Sales AI in CRM is revolutionizing the way pharmaceutical companies interact with healthcare professionals (HCPs), patients, and other stakeholders. This not only improves engagement but also positions the pharma company as a valuable partner in the healthcare ecosystem.
A long-awaited report from the US Federal Trade Commission (FTC) on pharmacy benefit managers (PBMs) is out – and will make uncomfortable reading for the pharma supply chain middlemen.Its central message is clear.
While the federal government has proposed negotiating the cost of drugs with pharma for Medicare, it still ignored the high costs hidden in plain sights, like patients who rely too much on prescription medications to tackle health problems addressed with lifestyle changes. It’s not going to be easy but using incentives can help.
Typically, results or new treatment prescriptions are simply uploaded to the portal with the doctors expected to give explanations during the appointment—even though the ability to provide additional information within the portal is readily available. However, only 32% of patients trust pharma-developed apps.
Consumers would ask their doctor about an advertised prescription drug in a perfect world. Most senior pharma people don’t have a marketing background, and agencies have been known to align data with what they want: more money. In our REAL world, that isn’t the way it happens. The research was straightforward.
However, despite being one of the biggest markets in pharma, diabetes drugmakers have a hard time standing out in the crowded field, and many patients still aren’t confident in their ability to manage their disease. Patients are willing to explore new prescription therapies as well, but most are unaware of their available options.
A Smarter Approach to Pharma Marketing Pharma marketing is evolving rapidly as artificial intelligence (AI) and analytics make it easier to interpret health datasuch as insurance claims, lab results, and patient recordswhile also leveraging engagement data to refine outreach strategies.
One study analyzed the drug ads of an anti-hypertensive drug in 210 issues of the NEJM between 1985 to 1996 and showed increased ad frequency was associated with an increase in prescriptions. As a result, just 27% of physicians say they find pharma websites to be a credible source of professional information. But what about online?
By introducing medication tracking to its existing iPhone Health app, Apple just did for prescription drug users what it did for anyone with a physical wallet or airplane boarding pass. including when to take each prescription drug ? The doctor will see you now. This scenario is no longer relegated to the distant future.
Paid social media advertising offers precise audience targeting, real-time analytics, and measurable engagement , making it an essential tool in modern pharma marketing. For pharma marketers, paid campaigns are more than just boosting posts on LinkedIn, Facebook, Twitter, or Instagram. By leveraging: Video content (e.g.,
Social media is part of our online lives, but too many people believe what they read regarding health information and prescription drugs. NOBODY goes to a pharma website and says “I’m going to ask for that drug!” Pharma websites need to evolve.
PBMs, insurers, pharma companies, and hospitals don’t want to give up their profits even if it’s better for the general population. But Express Scripts, which manages pharmacy benefits for 100 million people, is telling pharmacies to dispense the more expensive Advair brand because it won’t cover Mylan’s generic.
SUMMARY: Pharma has been relying on digital agencies for too long but agencies can’t begin to understand your audience like brand team members. Pharma brands have come to rely too heavily on digital marketing agencies for a range of services, from paid media to actual website development. A VP is not a good start.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content